Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Change in Account Payables (2016 - 2026)

Exelixis (EXEL) posted quarterly Change in Account Payables of -$17.9 million for Q2 2026, down 310.53% year-over-year from $8.5 million in Q2 2025, and down 38.74% quarter-over-quarter from -$12.9 million in Q1 2026.

Analysis

Exelixis (EXEL) Change in Account Payables (2016 - 2026) Analysis & Trends

Exelixis' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$17.9 million for Q2 2026.

  • In Q2 2026, Change in Account Payables fell 310.53% year-over-year to -$17.9 million; the TTM figure through Apr 2026 stood at -$76.6 million (down 466.94% YoY), while the FY2026 annual figure was -$50.2 million, down 129.15% from the prior year.
  • Change in Account Payables for Q2 2026 stood at -$17.9 million, down from -$12.9 million in the prior quarter.
  • The five-year high for Change in Account Payables was $43.6 million in Q4 2023, with the low at -$63.5 million in Q3 2025.
  • The 5-year median for Change in Account Payables is $2.2 million (2025), against an average of -$968823.5.
  • Peak annual rise in Change in Account Payables reached 3481.14% in 2024, while the deepest fall reached 8332.45% in 2024.
  • Exelixis' Change in Account Payables stood at $19.8 million in 2022, then soared by 120.68% to $43.6 million in 2023, then tumbled by 39.52% to $26.4 million in 2024, then slumped by 32.73% to $17.8 million in 2025, then slumped by 200.8% to -$17.9 million in 2026.
  • Business Quant data shows EXEL's Change in Account Payables at -$17.9 million in Q2 2026, -$12.9 million in Q1 2026, and $17.8 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 5.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 5.03 Mn
Apr 3, 2026 -17.90 Mn
Jan 2, 2026 -12.90 Mn
Oct 3, 2025 17.76 Mn
Jul 4, 2025 -63.51 Mn
Apr 4, 2025 8.50 Mn
Jan 3, 2025 2.24 Mn
Sep 27, 2024 26.39 Mn
Jun 28, 2024 -16.28 Mn
Mar 29, 2024 -34.25 Mn
Dec 29, 2023 43.64 Mn
Sep 29, 2023 737,000.00
Jun 30, 2023 5.32 Mn
Mar 31, 2023 416,000.00
Dec 30, 2022 19.77 Mn
Sep 30, 2022 -14.32 Mn
Jul 1, 2022 10.53 Mn
Apr 1, 2022 7.38 Mn
Dec 31, 2021 21.23 Mn
Oct 1, 2021 8.00 Mn